Marinomed Biotech AG | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 04/10/2025 at 07:50, 3 days 10 hours ago

Marinomed Biotech AG lance de nouveaux collyres en Autriche

Marinomed Biotech Unither Pharmaceuticals Collyre À La Carraghénane Lancement En Autriche Réglementation Des Dispositifs Médicaux
BRIEF

published on 04/10/2025 at 07:50, 3 days 10 hours ago

Marinomed Biotech AG Launches New Eye Drops in Austria

Marinomed Biotech Medical Device Regulation Unither Pharmaceuticals Carragelose Eye Drops Austria Launch
PRESS RELEASE

published on 04/10/2025 at 07:45, 3 days 10 hours ago

Marinomed Biotech AG: Launch of new moisturizing Carragelose eye drops in Austria
Marinomed Biotech AG launches new moisturizing Carragelose eye drops, 'Coldamaris protect', in Austria. Product complements existing portfolio, supports earn-out milestones, and meets new medical device regulation

Marinomed Biotech AG Carragelose Austria Medical Device Regulation Eye Drops
BRIEF

published on 03/27/2025 at 07:50, 17 days 10 hours ago

Marinomed vise la croissance après sa restructuration

Restructuration Expansion Mondiale Marinomed Biotech Rhinite Allergique Budesolv
BRIEF

published on 03/27/2025 at 07:50, 17 days 10 hours ago

Marinomed Targets Growth After Restructuring

Global Expansion Restructuring Marinomed Biotech Allergic Rhinitis Budesolv
PRESS RELEASE

published on 03/27/2025 at 07:45, 17 days 10 hours ago

Marinomed focuses on growth after successful restructuring
Marinomed Biotech AG focuses on growth post-successful restructuring with innovative nasal corticosteroid Budesolv for allergic rhinitis treatment and global expansion plans

Global Expansion Restructuring Marinomed Biotech AG Allergic Rhinitis Budesolv
BRIEF

published on 02/28/2025 at 10:25, 1 month 13 days ago

Marinomed Biotech Finalizes Carragelose Business Sale to Unither

Strategic Investment Carragelose Marinomed Unither Pharmaceuticals Biotech Sale
BRIEF

published on 02/28/2025 at 10:25, 1 month 13 days ago

Marinomed Biotech finalise la vente de son activité Carragelose à Unither

Investissement Stratégique Marinomé Carraghénose Unither Pharmaceutique Vente De Biotechnologie
PRESS RELEASE

published on 02/28/2025 at 10:20, 1 month 13 days ago

Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals
Marinomed Biotech AG successfully completes the sale of Carragelose business to Unither Pharmaceuticals, marking a strategic decision. Deal includes upfront payment of EUR 5 million and transition service agreement

Strategic Decision Marinomed Biotech AG Sale Completion Unither Pharmaceuticals Carragelose Business
BRIEF

published on 01/31/2025 at 12:15, 2 months 13 days ago

Marinomed Biotech AG Announces Management Board Changes

CFO Resignation Marinomed Biotech AG Financial Restructuring Management Changes Marinosolv Platform

Accesswire

Published on 04/12/2025 at 15:45, 1 day 2 hours ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 16 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 18 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 18 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 18 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 20 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 1 day 23 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 2 days ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 2 days ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 2 days ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 2 days ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 2 days ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 2 days ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 2 days ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 2 days ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE